Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 281 - 300 results of 3,938 for search 'significantly ((((((largest decrease) OR (larger decrease))) OR (nn decrease))) OR (mean decrease))', query time: 0.43s Refine Results
  1. 281
    Mean AIV-H9N2 shedding titer (Log<sub>10</sub>) in oropharyngeal swabs.

    Mean AIV-H9N2 shedding titer (Log<sub>10</sub>) in oropharyngeal swabs. by Oumayma Arbani (21001472)

    Published 2025
    Save to List
    Saved in:
  2. 282
    ECoG timescales decrease during spatial attention.

    ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

    Published 2025
    “…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
    Save to List
    Saved in:
  3. 283
    The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in high-fat diet (HFD)/ streptozotocin (STZ) -induced diabetic kidneys.

    The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in high-fat diet (HFD)/ streptozotocin (STZ) -induced diabetic kidneys. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 284
    The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in HK-2 cells.

    The effects of CGA on NLRP3 inflammasome and the Nrf2 pathway in HK-2 cells. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 285
    The biochemical data and protein expression levels.

    The biochemical data and protein expression levels. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 286
    Effects of CGA on renal biochemical markers.

    Effects of CGA on renal biochemical markers. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 287
    The effects of CGA on renal histopathological injury.

    The effects of CGA on renal histopathological injury. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 288
    Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells.

    Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 289
    Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty.

    Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 290
    Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA.

    Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 291
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 292
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 293
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 294
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 295
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 296
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 297
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 298
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 299
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 300
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: